Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Zeuzem

Showing results (1-10 of 862) with videos related to

Pageof 87
Sort By:
Deutsche Medizinische Wochenschrift (1946)|December 4, 2018
[Treatment of Hepatitis C: State of the Art 2018]Stefan Zeuzem
Zeitschrift Fur Gastroenterologie|August 12, 2014
[Prof. Dr. med. Peter Galle]Stefan Zeuzem
Zeitschrift Fur Gastroenterologie|July 14, 2020
[Choose wisely - a critical assessment]Stefan Zeuzem
Methods in Molecular Medicine|February 26, 2004
Overview of commercial HBV assays systemsStefan Zeuzem
Journal of Hepatology|June 22, 2002
Favourable and disappointing lessons from viral kineticsStefan Zeuzem
Journal of Hepatology|September 1, 2004
Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?Stefan Zeuzem
Journal of Hepatology|June 17, 2008
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patientsStefan Zeuzem
Antiviral Therapy|April 28, 2006
The American Association For the Study of Liver Diseases: new perspectives in the treatment of hepatitis CStefan Zeuzem
Gastroenterology|November 26, 2009
Do differences in pegylation of interferon alfa matter?Stefan Zeuzem
Deutsches Arzteblatt International|February 2, 2017
Treatment Options in Hepatitis CStefan Zeuzem
Pageof 87

Showing results (1-10 of 862) with videos related to

Sort By:
Pageof 87
Deutsche Medizinische Wochenschrift (1946)|December 4, 2018
[Treatment of Hepatitis C: State of the Art 2018]Stefan Zeuzem
Zeitschrift Fur Gastroenterologie|August 12, 2014
[Prof. Dr. med. Peter Galle]Stefan Zeuzem
Zeitschrift Fur Gastroenterologie|July 14, 2020
[Choose wisely - a critical assessment]Stefan Zeuzem
Methods in Molecular Medicine|February 26, 2004
Overview of commercial HBV assays systemsStefan Zeuzem
Journal of Hepatology|June 22, 2002
Favourable and disappointing lessons from viral kineticsStefan Zeuzem
Journal of Hepatology|September 1, 2004
Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?Stefan Zeuzem
Journal of Hepatology|June 17, 2008
Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patientsStefan Zeuzem
Antiviral Therapy|April 28, 2006
The American Association For the Study of Liver Diseases: new perspectives in the treatment of hepatitis CStefan Zeuzem
Gastroenterology|November 26, 2009
Do differences in pegylation of interferon alfa matter?Stefan Zeuzem
Deutsches Arzteblatt International|February 2, 2017
Treatment Options in Hepatitis CStefan Zeuzem
Pageof 87